Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

States Will Continue To Push For PBM Regulation Despite Maine Ruling

Executive Summary

States will continue to pursue plans to regulate the pharmacy benefit management industry even though Maine's "transparency" law has been held up in federal court, Massachusetts Assistant Attorney General Christopher Smith told an American Conference Institute meeting March 23 in Washington, D.C
Advertisement

Related Content

Formulary Discounts Shield Manufacturers From Price Controls – PBMs
Formulary Discounts Shield Manufacturers From Price Controls – PBMs
HHS Inspector General Meets With PBMs; Medco Explains “Transparency”
Lilly Zyprexa Marketing Info Sought By Philadelphia U.S. Attorney
HHS Inspector General Meets With PBMs; Medco Explains “Transparency”
HHS Inspector General Meets With PBMs; Medco Explains “Transparency”
PBM Regulation In Maine Blocked By Federal Court; ERISA Preempts State
PBM Regulation In Maine Blocked By Federal Court; ERISA Preempts State
Abbott “Nominal Prices” Cited In Medco Suit; “Improper” Payments Alleged
Advertisement
UsernamePublicRestriction

Register

PS043641

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel